[1]
“Limited Systemic Exposure with Topical Glycopyrronium Tosylate across Multiple Studies in Healthy Volunteers and Patients with Primary Axillary Hyperhidrosis”, J of Skin, vol. 3, p. S55, Nov. 2019, doi: 10.25251/skin.3.supp.55.